InvestorsHub Logo
Followers 17
Posts 1103
Boards Moderated 0
Alias Born 04/07/2020

Re: None

Tuesday, 03/30/2021 10:39:53 PM

Tuesday, March 30, 2021 10:39:53 PM

Post# of 232921
"Nader Pourhassan, Ph.D., President and Chief Executive Officer of CytoDyn, commented, “We are very pleased to initiate sales of Vyrologix™ (leronlimab) in the Philippines as soon as we have CSP approved for patients."

https://www.cytodyn.com/investors/news-events/press-releases/detail/498/chiral-pharma-corp-to-assist-philippine-physicians-apply

"announced today the Republic of the Philippines, Department of Health, Food and Drug Administration (“Philippines FDA”) has approved the use of leronlimab to treat a COVID-19 patient under Compassionate Special Permit (“CSP”) pursuant to FDA Order No. 2016-005."

https://www.cytodyn.com/investors/news-events/press-releases/detail/510/the-philippines-fda-approves-the-use-of-leronlimab-to-treat

"CytoDyn will dedicate at least 200,000 vials (100,000 doses) of leronlimab from its inventory to Chiral Pharma Corp. for potential sales in the Philippines"

https://www.cytodyn.com/investors/news-events/press-releases/detail/498/chiral-pharma-corp-to-assist-philippine-physicians-apply

"The Company is shipping leronlimab to its partner, Chiral Pharma Corporation, its importer in the Philippines."


https://www.cytodyn.com/investors/news-events/press-releases/detail/510/the-philippines-fda-approves-the-use-of-leronlimab-to-treat


It's happening people, the wheels are turning, the flood gates are open





Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News